Functional characterization of naturally occurring genetic variants in the human TLR1-2-6 gene family

Human Mutation

Volumn 32, Issue 6, 2011, Pages 643-652

  Ben Ali, Meriem ^a,b   Corre, Beatrice ^a,b   Manry, Jérémy ^a,b   Barreiro, Luis B ^c   Quach, Hélène ^a,b   Boniotto, Michele ^a,b   Pellegrini, Sandra ^a,b   Quintana Murci, Lluís ^a,b  

^a INSTITUT PASTEUR   (France)

^b CNRS   (France)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

Innate immunity; NF B activity; Nonsynonymous mutations; TLRs

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR AGONIST;

AMINO ACID SEQUENCE; ARTICLE; CELL LINE; GENE ACTIVATION; GENE FUNCTION; GENETIC VARIABILITY; HUMAN; PRIORITY JOURNAL;

EVOLUTION, MOLECULAR; GENETIC VARIATION; HEK293 CELLS; HUMANS; MUTATION; POPULATION; TOLL-LIKE RECEPTOR 1; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 6;

EID: 79957611770     PISSN: 10597794     EISSN: 10981004     Source Type: Journal    
DOI: 10.1002/humu.21486     Document Type: Article

References (46)

1. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, Kondrashov AS, Sunyaev SR. 2010. A method and server for predicting damaging missense mutations. Nat Methods 7:248-249.
2. Akira S, Takeda K. 2004. Toll-like receptor signalling. Nat Rev Immunol 4:499-511.
3. Akira S, Uematsu S, Takeuchi O. 2006. Pathogen recognition and innate immunity. Cell 124:783-801.
4. Barbalat R, Lau L, Locksley RM, Barton GM. 2009. Toll-like receptor 2 on inflammatory monocytes induces type I interferon in response to viral but not bacterial ligands. Nat Immunol 10:1200-1207.
5. Barreiro LB, Ben-Ali M, Quach H, Laval G, Patin E, Pickrell JK, Bouchier C, Tichit M, Neyrolles O, Gicquel B, Kidd JR, Kidd KK, Alcais A, Ragimbeau J, Pellegrini S, Abel L, Casanova JL, Quintana-Murci L. 2009. Evolutionary dynamics of human Toll-like receptors and their different contributions to host defense. PLoS Genet 5:e1000562.
6. Bauernfeind F, Hornung V. 2009. TLR2 joins the interferon gang. Nat Immunol 10:1139-1141.
7. Berdeli A, Celik HA, Ozyurek R, Dogrusoz B, Aydin HH. 2005. TLR-2 gene Arg753Gln polymorphism is strongly associated with acute rheumatic fever in children. J Mol Med 83:535-541.
8. Beutler B. 2004. Inferences, questions and possibilities in Toll-like receptor signalling. Nature 430:257-263.
9. Beutler B, Hoebe K, Du X, Ulevitch RJ. 2003. How we detect microbes and respond to them: the Toll-like receptors and their transducers. J Leukoc Biol 74:479-485.
10. Beutler B, Rehli M. 2002. Evolution of the TIR, tolls and TLRs: functional inferences from computational biology. Curr Top Microbiol Immunol 270:1-21.
11. Casanova JL, Abel L, Quintana-Murci L. 2011. Human TLRs and IL-1Rs in host defense: natural insights from evolutionary, epidemiological, and clinical genetics. Annu Rev Immunol (in press).
12. Enard D, Depaulis F, Roest Crollius H. 2010. Human and non-human primate genomes share hotspots of positive selection. PLoS Genet 6:e1000840.
13. Etokebe GE, Skjeldal F, Nilsen N, Rodionov D, Knezevic J, Bulat-Kardum L, Espevik T, Bakke O, Dembic Z. 2010. Toll-like receptor 2 (P631H) mutant impairs membrane internalization and is a dominant negative allele. Scand J Immunol 71:369-381.
14. Garantziotis S, Hollingsworth JW, Zaas AK, Schwartz DA. 2008. The effect of toll-like receptors and toll-like receptor genetics in human disease. Annu Rev Med 59:343-359.
15. Georgel P, Macquin C, Bahram S. 2009. The heterogeneous allelic repertoire of human toll-like receptor (TLR) genes. PLoS One 4:e7803.
16. Gong J, Wei T, Zhang N, Jamitzky F, Heckl WM, Rossle SC, Stark RW. 2010. TollML: a database of toll-like receptor structural motifs. J Mol Model 16:1283-1289.
17. Hawn TR, Misch EA, Dunstan SJ, Thwaites GE, Lan NT, Quy HT, Chau TT, Rodrigues S, Nachman A, Janer M, Hien TT, Farrar JJ, Aderem A. 2007. A common human TLR1 polymorphism regulates the innate immune response to lipopeptides. Eur J Immunol 37:2280-2289.
18. Janeway Jr CA, Medzhitov R. 2002. Innate immune recognition. Annu Rev Immunol 20:197-216.
19. Johnson CM, Lyle EA, Omueti KO, Stepensky VA, Yegin O, Alpsoy E, Hamann L, Schumann RR, Tapping RI. 2007. Cutting edge: a common polymorphism impairs cell surface trafficking and functional responses of TLR1 but protects against leprosy. J Immunol 178:7520-7524.
20. Kang JY, Nan X, Jin MS, Youn SJ, Ryu YH, Mah S, Han SH, Lee H, Paik SG, Lee JO. 2009. Recognition of lipopeptide patterns by Toll-like receptor 2-Toll-like receptor 6 heterodimer. Immunity 31:873-884.
21. Kawai T, Akira S. 2006. Innate immune recognition of viral infection. Nat Immunol 7:131-137.
22. Kawai T, Akira S. 2007. TLR signaling. Semin Immunol 19:24-32.
23. Kijpittayarit S, Eid AJ, Brown RA, Paya CV, Razonable RR. 2007. Relationship between Toll-like receptor 2 polymorphism and cytomegalovirus disease after liver transplantation. Clin Infect Dis 44:1315-1320.
24. Kimbrell DA, Beutler B. 2001. The evolution and genetics of innate immunity. Nat Rev Genet 2:256-267.
25. Kormann MS, Ferstl R, Depner M, Klopp N, Spiller S, Illig T, Vogelberg C, von Mutius E, Kirschning CJ, Kabesch M. 2009. Rare TLR2 mutations reduce TLR2 receptor function and can increase atopy risk. Allergy 64:636-642.
26. Lemaitre B, Hoffmann J. 2007. The host defense of Drosophila melanogaster. Annu Rev Immunol 25:697-743.
27. Leulier F, Lemaitre B. 2008. Toll-like receptors-taking an evolutionary approach. Nat Rev Genet 9:165-178.
28. Ma X, Liu Y, Gowen BB, Graviss EA, Clark AG, Musser JM. 2007. Full-exon resequencing reveals toll-like receptor variants contribute to human susceptibility to tuberculosis disease. PLoS One 2:e1318.
29. Medzhitov R. 2001. Toll-like receptors and innate immunity. Nat Rev Immunol 1:135-145.
30. Medzhitov R, Janeway Jr CA. 1997. Innate immunity: the virtues of a nonclonal system of recognition. Cell 91:295-298.
31. Medzhitov R, Janeway Jr C. 2000. Innate immunity. N Engl J Med 343:338-344.
32. Merx S, Neumaier M, Wagner H, Kirschning CJ, Ahmad-Nejad P. 2007. Characterization and investigation of single nucleotide polymorphisms and a novel TLR2 mutation in the human TLR2 gene. Hum Mol Genet 16:1225-1232.
33. Misch EA, Macdonald M, Ranjit C, Sapkota BR, Wells RD, Siddiqui MR, Kaplan G, Hawn TR. 2008. Human TLR1 deficiency is associated with impaired mycobacterial signaling and protection from leprosy reversal reaction. PLoS Negl Trop Dis 2:e231.
34. Ogus AC, Yoldas B, Ozdemir T, Uguz A, Olcen S, Keser I, Coskun M, Cilli A, Yegin O. 2004. The Arg753GLn polymorphism of the human toll-like receptor 2 gene in tuberculosis disease. Eur Respir J 23:219-223.
35. Okusawa T, Fujita M, Nakamura J, Into T, Yasuda M, Yoshimura A, Hara Y, Hasebe A, Golenbock DT, Morita M, Kuroki Y, Ogawa T, Shibata K. 2004. Relationship between structures and biological activities of mycoplasmal diacylated lipopeptides and their recognition by toll-like receptors 2 and 6. Infect Immun 72:1657-1665.
36. Omueti KO, Mazur DJ, Thompson KS, Lyle EA, Tapping RI. 2007. The polymorphism P315L of human toll-like receptor 1 impairs innate immune sensing of microbial cell wall components. J Immunol 178:6387-6394.
37. Ozinsky A, Underhill DM, Fontenot JD, Hajjar AM, Smith KD, Wilson CB, Schroeder L, Aderem A. 2000. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. Proc Natl Acad Sci USA 97:13766-13771.
38. Pickrell JK, Coop G, Novembre J, Kudaravalli S, Li JZ, Absher D, Srinivasan BS, Barsh GS, Myers RM, Feldman MW, Pritchard JK. 2009. Signals of recent positive selection in a worldwide sample of human populations. Genome Res 19:826-837.
39. Roach JC, Glusman G, Rowen L, Kaur A, Purcell MK, Smith KD, Hood LE, Aderem A. 2005. The evolution of vertebrate Toll-like receptors. Proc Natl Acad Sci USA 102:9577-9582.
40. Smirnova I, Mann N, Dols A, Derkx HH, Hibberd ML, Levin M, Beutler B. 2003. Assay of locus-specific genetic load implicates rare Toll-like receptor 4 mutations in meningococcal susceptibility. Proc Natl Acad Sci USA 100:6075-6080.
41. Takahashi M, Matsuda F, Margetic N, Lathrop M. 2003. Automated identification of single nucleotide polymorphisms from sequencing data. J Bioinform Comput Biol 1:253-265.
42. Takeuchi O, Kawai T, Muhlradt PF, Morr M, Radolf JD, Zychlinsky A, Takeda K, Akira S. 2001. Discrimination of bacterial lipoproteins by Toll-like receptor 6. Int Immunol 13:933-940.
43. Takeuchi O, Sato S, Horiuchi T, Hoshino K, Takeda K, Dong Z, Modlin RL, Akira S. 2002. Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins. J Immunol 169:10-14.
44. Tantisira K, Klimecki WT, Lazarus R, Palmer LJ, Raby BA, Kwiatkowski DJ, Silverman E, Vercelli D, Martinez FD, Weiss ST. 2004. Toll-like receptor 6 gene (TLR6): single-nucleotide polymorphism frequencies and preliminary association with the diagnosis of asthma. Genes Immun 5:343-346.
45. West AP, Koblansky AA, Ghosh S. 2006. Recognition and signaling by toll-like receptors. Annu Rev Cell Dev Biol 22:409-437.
46. Wong SH, Gochhait S, Malhotra D, Pettersson FH, Teo YY, Khor CC, Rautanen A, Chapman SJ, Mills TC, Srivastava A, Rudko A, Freidin MB, Puzyrev VP, Ali S, Aggarwal S, Chopra R, Reddy BS, Garg VK, Roy S, Meisner S, Hazra SK, Saha B, Floyd S, Keating BJ, Kim C, Fairfax BP, Knight JC, Hill PC, Adegbola RA, Hakonarson H, Fine PE, Pitchappan RM, Bamezai RN, Hill AV, Vannberg FO. 2010. Leprosy and the adaptation of human toll-like receptor 1. PLoS Pathog 6:e1000979.